期刊文献+

中国人群慢性淋巴细胞白血病免疫球蛋白重链可变区基因组成及突变分析 被引量:4

Immunoglobulin variable heavy chain region genetic constitution and mutation status in Chinese patients with chronic lymphocytic leukemia
原文传递
导出
摘要 目的 研究中国慢性淋巴细胞白血病(chronic lymphocytic leukemia,CLL)患者免疫球蛋白重链可变区(immunoglobulin variable heavy chain region,IGVH)基因各个片段的组成以及突变情况。方法 应用多重PCR技术扩增64例CLL患者的IGVH基因片段,纯化PCR扩增产物后直接测序,应用IMGT/V-QUEST及IGBlast数据库分析,明确VH基因有无突变和突变位置,以及VH、DH、JH家族各个成员组成情况。结果 64例CLL患者中,VH3家族31例(48%)、VH4家族26例(41%)、VH1家族4例(6%)、VH2家族2例(3%)、VH7家族1例(2%)。44例患者发生体细胞突变,占CLL患者的69%;20例无突变,占CLL患者的3l%,其中6例(9%)VH基因的同源性为100%。VH4家族中有9例无突变(9/26,35%);VH3家族中8例无突变(8/31,26%);VH1家族中1例无突变(1/4,25%)。在所检测的CLI,标本中,VH4—34是最常见的VH基因片段,检测出8例(13%),其中无突变3例;其次为VH4—59,检测出7例(11%),无突变者3例。DH基因中DH3家族最常见,有25例(39%);其中11例(11/20,55%)出现在无突变组中。无突变组中最常见的DH基因片段为DH3—10和DH3—22,各为4例(4/20,20%)。JH基因中JH6家族最常见,检测出23例(36%),其中9例出现在无突变组中(9/20,45%)。结论 中国CLL患者IGVH基因家族表达比例和突变情况与西方国家存在显著差异,推测可能与不同的种族和环境中的抗原选择有关,其预后意义有待进一步探讨。 Objective To evaluate the genetic constitution and mutation status of the immunoglobulin variable heavy chain region (IGVH) gene expression in Chinese patients with chronic lymphocytic leukemia (CLL). Methods The IGVH mutation was detected by multiplex PCR and direct sequencing of the purified PCR products from 64 CLL patients. The segments of VH, DH and JH family and mutations were analyzed by IMGT/V-QUEST and IGBlast. Results In the 64 patients, the most common usage was VH3 (31/64, 48%), followed byVH4 (26/64, 41%), VH1 (4/64, 6%), VH2 (2/64, 3%) and VH7 (1/64, 2%). The results also showed that 44 patients (69%) had mutated VH, 6 cases (9%) had identical germline sequences. Among the 64 sequences of DH segments, DH3 gene family was used most frequently (25/64, 39%), among which 11 cases had unmutated VH. The most frequent usage of the JH segments was JH6. Conclusion There is significant difference in the frequency of the IGVH gene family in Chinese CLL patients compared to Western patients, suggesting the involvement of antigen selection in different ethnic and/or environmental factors in CLL disease initiation, and its prognostic significance needs further investigation.
出处 《中华医学遗传学杂志》 CAS CSCD 北大核心 2009年第2期196-199,共4页 Chinese Journal of Medical Genetics
基金 江苏省医学领军人才基金(IJ200623) 江苏省医学重点人才基金(RC2007042) 江苏省自然科学基金(BK2007249) 江苏省社会发展计划基金(BS2007075)
关键词 慢性淋巴细胞白血病 免疫球蛋白重链可变区 基因突变 chronic lymphocytic leukemia immunoglobulin variable heavy chain region gene mutation
  • 相关文献

参考文献7

  • 1李丽,徐卫,李建勇.慢性淋巴细胞白血病预后因素研究进展[J].中华内科杂志,2006,45(9):781-783. 被引量:17
  • 2郑文娟,陈丽娟,吴雨洁,李丽,徐卫,李建勇.应用多重PCR技术检测慢性淋巴细胞白血病IgVH基因突变[J].中国实验血液学杂志,2006,14(6):1101-1104. 被引量:8
  • 3Mauerer K, Zahrieh D, Gorgun G, et al. Immunoglobulin gene segment usage, location and immunogenicity in mutated and unmutated chronic lymphocytic leukaemia. Br J Haematol, 2005, 129 : 499-510.
  • 4Widhopf GF, Rassenti LZ, Toy TL, et al. Chronic lymphocytic leukemia B cells of more than 1% of patients express virtually identical immunoglobulins. Blood, 2004,104 : 2499-2504.
  • 5Tobin G, Thunberg U, Karlsson K, et al. Subsets with restricted immunoglobulin gene rearrangement features indicate a role for antigen selection in the development of ebronic lymphocytic leukemia. Blood, 2004,104 : 2879-2885.
  • 6Duke VM, Gandini D, Sherrington PD, et al. V(H) gene usage differs in germline and mutated B cell chronic lympaocytic leukemia. Haematologica, 2003,88: 1259-1271.
  • 7Ghia P, Stamatopoulos K, Belessi C, et al. Geographic patterns and pathogenetic implications of IGHV gene usage in chronic lymphocytic leukemia: the lesson of the IGHV3-21 gene. Blood, 2005,105 : 1678-1685.

二级参考文献32

  • 1Aoun P,Blair HE,smith LM,et al.Fluorescence in situ hybridization detection of cytogenetic abnormalities in B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma.Leuk Lymphoma,2004,45:1595-1603.
  • 2Dohner H,stilgenbauer S,Benner A,et al.Genomic aberrations and survival in chronic lymphocytic leukemia.N Engl J Med,2000,343:1910-1916.
  • 3Stilgenbauer S,Dohner H.Molecular genetics and its clinical relevance.Hematol Oncol Clin North Am,2004,18:827-848.
  • 4Cuneo A,Rigolin GM,Bigoni R,et al.Chronic lymphocytic leukemia with 6q-shows distinct hematological features and intermediate prognosis.Leukemia,2004,18:476-483.
  • 5Del Poeta G,Maurillo L,Venditti A,et al.Clinical significance of CD38 expression in chronic lymphocytic leukemia.Blood,2001,98:2633-2639.
  • 6Gentile M,Mauro FR,Calabrese E,et al.The prognostic value of CD38 expression in chronic lymphocytic leukaemia patients studied prospectively at diagnosis:a single institute experience.Br J Haematol,2005,130:549-557.
  • 7Thornton PD,Fernandez C,Giustolisi GM,et al.CD38 expression as a prognostic indicator in chronic lymphocytic leukaemia.Hematol J,2004,5:145-151.
  • 8Orchard JA,Ibbotson RE,Davis Z,et al.ZAP-70 expression and prognosis in chronic lymphocytic leukaemia.Lancet,2004,363:105-111.
  • 9Schroers R,Griesinger F,Trumper L,et al.Combined analysis of ZAP-70 and CD38 expression as a predictor of disease progression in B-cell chronic lymphocytic leukemia.Leukemia,2005,19:750-758.
  • 10Vasconcelos Y,Davi F,Levy V,et al.Binet's staging system and VH genes are independent but complementary prognostic indicators in chronic lymphocytic leukemia.J Clin Oncol,2003,21:3928-3932.

共引文献23

同被引文献47

  • 1Lefranc MP, Lefranc G. The Immunoglobulin FactsBook, Academic Press, 2001: ISBN:012441351X 458 pages.
  • 2Stamatopoulos K, Belessi C, Moreno C, et al. Over 20% of patients with chronic lymphocytic leukemia carry stereotyped receptors: pathogenetic implications and clinical correlations. Blood, 2007 ; 109:259 - 270.
  • 3Tobin G, Thunberg U, Johnson A, et al. Chronic lymphocytic leukemias utilizing the VH3-21 gene display highly restricted Vlambda2-14 gene use and homologous CDR3s: implicating recognition of a common antigen epitope. Blood, 2003 ; 101:4952 - 4957.
  • 4Tobin G, Thunberg U, Johnson A, et al. Somatically mutated lg V( H)3-21 genes characterize a new subset of chronic lymphocytic leukemia. Blood, 2002 ;99:2262 -2264.
  • 5Lin K, Manocha S, Harris RJ, et al. High frequency of p53 dysfunction and low level of VH mutation in chronic lymphocytic leukemia patients using the VH3-21 gene segment. Blood, 2003; 102 : 1145 - 1146.
  • 6Philippe J, Janssens A, Smits K, et al. Prognostic value of specific VH-genes in CLL [abstract]. Leuk Lymph, 2003 ;44 : $40.
  • 7Abramenko I, Bilous N, Kryachok I, et al. IGHV3-21 gene expression in patients with B-cell chronic lymphocytic leukemia in Ukraine. Exp Oncol. 2007 ;29:226 - 230.
  • 8Ghia P, Stamatopoulos K, Belessi C, et al. Geographic patterns and pathogenetic implications of IGHV gene usage in chronic lymphocytic leukemia: the lesson of the IGHV3-21 gene. Blood, 2005; 105:1678 - 1685.
  • 9Bomben R, Dal Bo M, Capello D, et al. Comprehensive characterization of IGHV3-21-expressing B-cell chronic lymphocytic leukemia: an Italian multicenter study. Blood, 2007 ;109 : 2989 - 2998.
  • 10Thorselius M, Krober A, Murray F, et al. Strikingly homologous immunoglobulin gene rearrangements and poor outcome in VH3-21- using chronic lymphocytic leukemia patients independent of geographic origin and mutational status. Blood, 2006 ;107:2889 - 2894.

引证文献4

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部